Can troponin T replace CK MBmass as 'gold standard' for Acute Myocardial Infarction ('AMI')?

Scandinavian Journal of Clinical and Laboratory Investigation, Supplement

Volumn 59, Issue 230, 1999, Pages 83-89

  Gerhardt, W ^a   Nordin, G ^a   Ljungdahl, L ^b  

^a Dept of Clinical Chemistry ^*  (Sweden)

^b Section of Cardiology   (Sweden)

Author keywords

'Gold standard' for AMI; Gradation of myocardial damage; TnT; Troponin T; WHO AMI criteria

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE MB; TROPONIN T; BIOLOGICAL MARKER; CREATINE KINASE; ISOENZYME;

ACUTE HEART INFARCTION; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEART MUSCLE INJURY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; STANDARD; ARTICLE; BLOOD; CLINICAL CHEMISTRY; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; HEART INFARCTION; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; SENSITIVITY AND SPECIFICITY; WORLD HEALTH ORGANIZATION;

BIOLOGICAL MARKERS; CHEMISTRY, CLINICAL; CREATINE KINASE; ELECTROCARDIOGRAPHY; HUMANS; ISOENZYMES; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; TROPONIN T; WORLD HEALTH ORGANIZATION;

EID: 0032601781     PISSN: 0085591X     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519909168331     Document Type: Conference Paper

References (16)

1. Report of the Joint International Society and Federation of Cardiology / World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation 1979; 59: 607-609.
2. ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction. JACC 1996; 28: 1328-1428.
3. Panthegini M. Diagnostic application of CK MBmass determination. Clin Chim Acta 1998; 272: 23-31.
4. Wu AHB. Analytical and clinical evaluation of new diagnostic tests for myocardial damage. Clin Chim Acta 1998; 272: 11-21.
5. Dati F, Panthegini M. Proposals from the IFCC Committee on Standardization of markers of Cardiac Damage (C_SMCD). In: Proceedings of the 7th Bergmeyer Conference 1999. Scand J Clin Lab Invest 1999; (This suppl.)
6. Gerhardt W, Ljungdahl L. Troponin T: A sensitive and specific diagnostic and prognostic marker of myocardial damage. Clin Chim Acta 1998; 272: 47-57.
7. Wu AHB, Apple F, Gibler B, Jesse R, Warshaw M, Valdes R. National Academy of Clinical Biochemistry: Guidelines for the Use of Cardiac Markers in Coronary Artery Diseases. Clin Chem 1999 (in preparation)
8. Margit Müller-Bardorff, Hallermayer K, Schöder Angelika, Ebert C, Borgya Anneliese, Gerhardt W et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem 1997; 43: 458-466.
9. Baum HJ, Braun S, Gerhardt W, Gilson G, Hafner G, Müller-Bardorff Margit, et al. Multicenter evaluation of a second-generation assay for cardiac troponin T. Clin Chem 1997; 43: 1877-1884.
10. Gerhardt W, Ljungdahl L, Herbert Ann-Kathrin. Troponin-T and CK MB (mass) in early diagnosis of myocardial injury. The Helsingborg Study, 1992. Clin Biochem 1993; 26: 231-40.
11. Gerhardt W, Ljungdahl L. Detection of Myocardial Damage by Serial Seterminations of Cardiac troponin T, CK MBmass, and TROPT rapid test. Cardiovascular Drugs and Therapy 1997; 11: 227-40.
12. Gerhardt W, Ljungdahl L. Rational diagnostic strategy in diagnosis of ischemic myocardial injury. S-troponin T and CK MB (mass) time series using individual baseline concentrations. Scand J Clin lab Invest 1993; 53: 47-59
13. Lindahl B. Relation Between Troponin T and the Risk of Subsequent Cardiac Events in unstable Coronary Artery Disease. Circulation 1996; 93: 1651-1657.
14. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA Hamm CW et al. Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial ischemia. New Engl J Med. 1996;335: 1333-1341
15. Hallermayer K. Use of Recombinant Human Cardiac Troponin T for Standardization of Third Generation Troponin T Assays. In: Proceedings of the 7th Bergmeyer Conference 1999. Scand J Clin Lab Invest 1999; (This SICLI suppl.)
16. Per Venge, Dept of Clin Chem, University of Uppsala (personal communication)